Form 8-K - Current report:
SEC Accession No. 0001493152-24-029174
Filing Date
2024-07-26
Accepted
2024-07-26 09:30:10
Documents
14
Period of Report
2024-07-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 36273
2 ex99-1.htm EX-99.1 26463
  Complete submission text file 0001493152-24-029174.txt   244561

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE immx-20240725.xsd EX-101.SCH 3015
4 XBRL LABEL FILE immx-20240725_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE immx-20240725_pre.xml EX-101.PRE 22359
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3814
Mailing Address 10573 W. PICO BLVD. #58 LOS ANGELES CA 90064
Business Address 11400 WEST OLYMPIC BLVD. SUITE 200 LOS ANGELES CA 90064 (888) 958-1084
Immix Biopharma, Inc. (Filer) CIK: 0001873835 (see all company filings)

EIN.: 454869378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41159 | Film No.: 241143753
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)